Half Yearly Report and Accounts
Sydney, Feb 29, 2016 AEST (ABN Newswire) - iQ3Corp Ltd (
ASX:IQ3) present their report, together with the financial statements of the Group, being the Company and its controlled entities, for the half-year ended 31 December 2015.
The principal activity of the Group during the half year was the provision of capital raising and corporate advisory services to listed and unlisted companies in the Life Science industry.
Review of operations
The Company was officially listed on the ASX on the 18th May 2015 after successfully raising $4,400,000 through an Initial Public Offering. The utilisation of funds during the year is being applied towards the development of the company's core offerings of:
- Corporate finance and advisory
- Mergers and acquisitions
- Capital raising and distribution channels
The net assets at half year-end were $2,940,583 compared to ($1,063,375) in the previous year. This provides an overall strengthening of working capital to fund the growth opportunities moving forward.
iQ3Corp is always seeking to deliver value to all its stakeholders and to ensure that we integrate sustainable opportunities into our overall strategy and operations. As previously announced, through our wholly owned subsidiary in the USA, IQ Capital (USA) LLC, we are applying to the US regulators, FINRA and SEC, in order to obtain the necessary licensure to extend our offering to the USA. From here we will be creating the pathway to give our life science clients access to capital markets at a global level. This is all part of our strategy in developing our role as the key global partner in the development of these life science companies.
To view the half year report, please visit:
http://media.abnnewswire.net/media/en/docs/ASX-IQ3-909712.pdf
About iQ3Corp Ltd
iQ3Corp Ltd (ASX:IQ3) is the world's first specialised life science corporate financial advisory and asset management firm.
iQ3Corp capitalises on its relationship with The iQ Group Global Companies and other industry participants such as academic institutions, financial market participants and other Life Science industry bodies, to provide a turnkey solution for capital raising from corporate inception to the capital markets.
iQ3 provides advice to life science companies on mergers and acquisitions, strategic matters, restructuring and capital structure, capital raising and corporate finance, as well as asset management services to corporations, partnerships, institutions, governments, and individuals.
| ||
|
